Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

EMG biofeedback plus multimodal exercise for TMD

Official title: The Effect of Emg-Biofeedback Based Relaxation Training Added to a Multimodal Exercise Program on Pain and Function in Patients With Temporomandibular Joint Dysfunction

Run by Yuzuncu Yil University · NCT07577687 · Data updated 2026-11-12

This study tests whether adding EMG-biofeedback-based relaxation to a multimodal exercise program can reduce pain and improve jaw function in people with temporomandibular joint dysfunction.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorYuzuncu Yil University
Academic / other
Locations1 site (Van, Tuşba)
StatusRecruiting
StartedJune 18, 2026
Main results expectedDecember 15, 2026
Study endsDecember 15, 2026
Registry record updatedNovember 9, 2026
Trial IDNCT07577687 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults diagnosed with Group 1 myofascial TMD ( RDC/TMD axis I 1a/1b) with TMJ pain for at least 3 months.

Probably not a fit

Patients who do not respond to neuromuscular relaxation or who have conditions excluded by eligibility may not see benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized trial, participants with myofascial TMD are assigned to receive a multimodal physiotherapy program with or without EMG-biofeedback-based relaxation training. The approach aims to increase awareness of jaw-muscle activity and promote neuromuscular relaxation alongside standard exercises and manual therapy. Outcomes include pain (VAS), pressure pain thresholds, mouth opening, range of motion, functional status, neck function, and quality of life, measured before and after the intervention. The study compares changes within each group and between groups to determine added benefit of biofeedback. The trial addresses whether this neuromuscular relaxation component can enhance the effectiveness of conservative TMD management.

Why it matters

Potential benefit: If successful, patients may experience greater pain relief and improved jaw function from a tailored, non-surgical treatment approach.

How similar studies have gone: Conservative multimodal physiotherapy has shown benefits for TMD, but evidence for EMG-biofeedback augmentation is limited and more data are needed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Having been diagnosed with TMD, meaning having been diagnosed with Group 1 (1a: myofascial pain - 1b: referral myofascial pain) within Axis 1 according to the RDC/TMD diagnostic system.
* Having experienced TMJ pain for at least 3 months
* Having a sufficient cognitive level to follow simple instructions and take tests.

Exclusion Criteria:

* Having a malignant condition in the TMJ and/or cervical spine and having undergone surgery,
* Having neurological or psychiatric disorders, pregnancy,
* Having a history of BTA (Botulinum toxin injection) within the last year,
* Having received physical therapy related to TMJ less than 6 months ago,
* Being under orthodontic treatment,
* Having uncontrolled diabetes,
* Having inflammatory rheumatic diseases (rheumatoid arthritis, etc.)

Where it's running

  • Van Yüzüncü Yıl University
    Van, Tuşba, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.